• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number PAH111002
Device Problems Retraction Problem (1536); Difficult to Advance (2920)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 03/05/2015
Event Type  Injury  
Event Description
The patient presented with an aneurysm in the popliteal artery.Three gore® viabahn® endoprostheses were used for the procedure.It was reported to gore that when the first viabahn device was implanted distally to the diseased lesion, the second device was introduced.When device deployment was initiated the deployment stopped suddenly after ¾ of deployment.It was not possible to pull the deployment line any further.While trying to pull the line the device moved proximally and fully deployed.The catheter was removed completely without any abnormalities but it was not possible to pull back the deployment line entirely.The line was cut at the very end of the introducer sheath and a third viabahn device was introduced to close the gap between the first and second one.The remaining deployment line remains in the patient.The final results was very good and the patient is doing well.
 
Manufacturer Narrative
A review of the manufacturing records for the device verified that the lot met all pre-release specifications.The imaging evaluation stated that the images provided do not allow for evaluation in relation to the event.The engineering evaluation is currently in process.
 
Manufacturer Narrative
The engineering evaluation stated that the following observations were made: the complete delivery system was returned to histology without the endoprosthesis.Approximately 161 cm of deployment line was returned with the device.The deployment line distal end had fibers of uneven length.The remainder of the device was unremarkable.Based on the device examination performed, no manufacturing anomalies were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
sandra whicker
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4642630
MDR Text Key5614957
Report Number2017233-2015-00196
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/31/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/10/2017
Device Catalogue NumberPAH111002
Device Lot Number13437884
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/30/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/10/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/15/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
TWO GORE® VIABAHN® ENDOPROSTHESES
Patient Outcome(s) Required Intervention;
Patient Age36 YR
Patient Weight90
-
-